0001179110-17-011785.txt : 20170823
0001179110-17-011785.hdr.sgml : 20170823
20170823170452
ACCESSION NUMBER: 0001179110-17-011785
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170821
FILED AS OF DATE: 20170823
DATE AS OF CHANGE: 20170823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PASQUALONE FRANK
CENTRAL INDEX KEY: 0001597334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 171047641
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
edgar.xml
FORM 4 -
X0306
4
2017-08-21
0
0001583107
Theravance Biopharma, Inc.
TBPH
0001597334
PASQUALONE FRANK
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP, Chief Comm Ops Officer
Ordinary Shares
2017-08-21
4
P
0
4000
26.3397
A
213180
D
Represents the weighted average purchase price per share for the open market purchase on August 21, 2017. The shares were purchased at prices ranging from $26.2499 to $26.4541 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Brett A. Grimaud, Attorney-in-Fact
2017-08-23